International Cannabis Weekly: 172

AN ADDITIONAL 13.4 MILLION AMERICANS NOW HAVE ACCESS TO ADULT-USE CANNABIS

Following a number of key votes in the US this week, recreational cannabis has been made legal in New Jersey, Arizona, Mississippi, Montana & South Dakota.

This had brought the total number of Americans living in states with access to legal cannabis, to 95.3 million.

To understand what this will mean for the country and how the economy of each state will be impacted, read the latest feature from Prohibition Partners, here.

LEARN MORE

HIGHLIGHTS

• A COMPREHENSIVE ANALYSIS OF SYNTHETIC V NATURAL CBD
• ADULT-USE CANNABIS LEGALISATION FACES REJECTION BY GERMAN PARLIAMENT

• GW Pharmaceuticals reports US$132.6 million in Epidiolex sales in Q3 2020 results.
• Aphria commences its 1,600 sq. metre medicinal cannabis cultivation facility in Neumünster.
• AMP signs a long-term supply agreement with Danish medical cannabis producer Schroll.
• Aphria and ODI Pharma execute supply agreement for medical cannabis in Poland.
• NHS repeatedly refuses to fund medical cannabis for epileptic children.

Following the news that five new states have passed ballots to legalise cannabis in the US, Prohibition Partners LIVE is set to host a variety of engaging discussions surrounding the most pertinent issues surrounding cannabis legalisation and all of the associated long term implications for the US.

Secure your place at our virtual event, here.

• Cannabis business leaders seek federal reform, despite Senate setback.
• Illinois adult-use cannabis sales reach record US$75 million in September.
• Massachusetts cannabis sales exceed US$1 billion since adult-use sales launched.
• Ohio taking petitions to expand the list of medical cannabis qualifying conditions.
• Aphria announces US$300 million strategic acquisition of SW Brewing Company.
• Montana launches an online hemp marketplace connecting sellers and buyers.
• Canopy Growth announces listing transfer from NYSE to NASDAQ stock exchange.

• Canadian cannabis stocks receive a boost as Biden election lead grows.
• Pure Extracts Technologies commences trading on the Canadian Securities Exchange.
• Cronos Group reports losses in Q3 2020 financial results while revenue improves.
• Canopy Growth launches new CBD-infused beverages in Canada.
• Cannabis producer Hexo Corp. reports net loss of CA$546 million in fiscal year results.
• Canadian study finds medical cannabis decreases the frequency of alcohol consumption.

• Final vote confirms New Zealand will continue the prohibition of adult-use cannabis.
• Medical cannabis company Entoura launches veteran-funding tool for cannabis treatments.
• Industrial hemp licences double in South Australia with 21 approved licences.
• Valens secures licence to sell and supply cannabis-based medicines in Australia.

• Final vote confirms New Zealand will continue the prohibition of adult-use cannabis.
• Medical cannabis company Entoura launches veteran-funding tool for cannabis treatments.
• Industrial hemp licences double in South Australia with 21 approved licences.
• Valens secures licence to sell and supply cannabis-based medicines in Australia.

• Sheikh receives first commercial cannabis export licence from Israeli Ministry of Health.
• South African advocates state the draft cannabis bill shows lack of understanding.
• Kenomed owners demand Israel stop the import of cannabis from abroad.
• South African investor plans to launch the first African medical cannabis investment fund.